NCT04756830View on ClinicalTrials.gov

A Study to Assess the Safety and Immunogenicity of the Coronavac Vaccine Against COVID-19

PHASE4UnknownINTERVENTIONAL
Enrollment

1,200

Participants

Timeline

Start Date

February 19, 2021

Primary Completion Date

September 30, 2021

Study Completion Date

June 30, 2023

Conditions
COVID-19
Interventions
BIOLOGICAL

Adsorbed COVID-19 (inactivated) Vaccine

Participants will receive two doses with 14-days interval of adsorbed COVID-19 (inactivated) vaccine

Trial Locations (2)

22281100

D'Or Institute for Research and Education, Rio de Janeiro

22211-230

Hospital Gloria D'Or - Hospitais Integrados da Gavea S/A, Rio de Janeiro

Sponsors

Collaborators (1)

Butantan Institute
All Listed Sponsors
collaborator

Butantan Institute

OTHER_GOV

lead

D'Or Institute for Research and Education

OTHER